The U.S. District Court for the District of Delaware is expected to enter a permanent injunction enjoining Impax Laboratories, Inc. from marketing Riluzole 50mg tablets until the expiration of Aventis…
The patent infringement lawsuit entitled Boehringer Ingelheim Pharmaceuticals, et al. v. Impax Laboratories remains pending in the U.S. District Court for the Northern District of California.
In July 2008, Boehringer Ingelheim…
The patent infringement complaint filed against Impax Laboratories, Inc. by Purdue Pharma Products L.P., Napp Pharmaceutical Group LTD., Biovail Laboratories International, SRL, and Ortho-McNeil-Janssen Pharmaceuticals, Inc. is in the discovery…
The patent infringement complaint filed by Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB against Impax Laboratories, Inc. is in discovery.
In March 2008, Pfizer filed the complaint…
No trial date has yet been set for the remaining patents-at-issue in the infringement lawsuit styled Aventis Pharmaceuticals Inc., et al. v. Impax Laboratories, Inc.
The Company is a defendant in…
Impax Laboratories, Inc. is preparing its answer to Eli Lilly and Company’s patent infringement complaint, according to its Form 10- Q/A filed with the U.S. Securities and Exchange Commission dated…
Merck & Co. Inc. and AstraZeneca LP’s lawsuit based on Dr. Reddy’s Laboratories’ filing of an abbreviated new drug application for esomeprazole (Nexium) remains pending in the District Court in…
A full trial on the merits of Abbott Cardiovascular Systems Inc.’s infringement claims against Medtronic Inc. entities is scheduled for Feb. 6, 2009, in the Netherlands.
On June 18, 2008, Abbott…
A new trial date on the remaining issues has not been set yet in Cross Medical Products Inc.’s patent infringement suit against Medtronic Inc.’s subsidiary, Medtronic Sofamor Danek Inc., in…
The amount of disputed royalties and interest related to certain of Medtronic, Inc.’s cardiac resynchronization therapy products has reached US$95 million, as of Oct. 24, 2008.
Medtronic is a licensee to…